OASIS-E: Patient Mood Interview, High Risk Drug Classes, & Special Treatments, Procedures, and Programs

The OASIS-E, to be implemented in January 2023, has multiple new items including the Patient Mood Interview, high risk drug classes, and an assessment of special treatments, procedures, and programs the home health patient is utilizing. The patient mood interview expands the previously assessed PHQ-2 to PHQ-9 to identify the presence of signs and symptoms of mood distress. Additionally, CMS has formally defined medications falling within the high-risk drug classes for OASIS-E which requires the clinician to assess for identifying indications of drug use.  Finally, the special treatments, procedures, and programs item will identify important medical treatments being utilized by the patient.  Previously, these therapies have been inconsistently documented in various areas of the patient’s clinical record. An in-depth look at these new items, along with use of scenarios, will prepare clinicians for implementation of OASIS-E.

October 27, 2022

12:00pm-1:00pm (CST)

1.0 CNE Hour

1.0 Clock Hour for Administrators

MAC Legacy is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


Registering Attendees Name & Email